TUBA1C and lung carcinoma: For example, knock-down TUBA1C by shRNA in lung cancer cells with ATM mutation showed a worse survival than cells with wild-type ATM (P = 0.01, one-sided Wilcoxon rank-sum test; Fig. 6A).